The EF-hand protein, S100A4, binds calcium ions and interacts specifically in vitro with protein targets. Elevated levels of S100A4 have been shown to produce a metastatic phenotype in independent models of breast cancer. The presence of S100A4 in the carcinoma cells of patients with different carcinomas is associated with reduced patient survival. In order to identify the region of the S100A4 molecule that is responsible for its metastasis-inducing properties, specific mutant S100A4 genes and proteins have been produced which contain targeted mutations to the two calcium-binding sites and a deletion of the last 15 amino-acid residues of the protein. The ability of the mutant proteins to bind to a potential specific target in vitro, nonmuscle myosin heavy chain, is correlated with their ability to cause motile, invasive and metastatic phenotypes. Mutation of the C-EF hand of S100A4 virtually abolished calcium binding, and motility/invasion in vitro, abolished interaction with a molecular target, and reduced metastasis induction by 2.5-3-fold. However, deletion of the last 15 amino acids of S100A4 reduced motility/invasion, target binding and metastasis-induction to similar extents as the C-EF-hand mutant, but reduced calcium binding by only 26%. The results suggest that the ability to interact with protein target(s) is important in S100A4-induced metastasis.
Introduction
Elevated levels of S100A4, a calcium-binding protein, have been strongly associated with the development of a metastatic phenotype. Transfection of the rat (Davies et al., 1993) or human (Lloyd et al., 1998 ) S100A4 gene and consequential expression of S100A4 protein in a benign nonmetastatic rat mammary cell line, Rama 37, induces a metastatic phenotype when the cells are injected into the mammary fat pads of syngeneic rats. In three transgenic models of mammary cancer (Ambartsumian et al., 1996 (Ambartsumian et al., , 1999 Davies et al., 1996) , S100A4 cooperates with growth-inducing activated oncogenes to yield growing metastases, predominantly in the lungs. In human prostate carcinoma cells, expression of S100A4 is associated with a malignant phenotype (Ke et al., 1997) and in breast, bladder, colorectal, gall bladder, esophageal and non-small-cell lung carcinomas (Kimura et al., 2000; Rudland et al., 2000; Ninomiya et al., 2001; Davies et al., 2002; Gongoll et al., 2002; Nakamura et al., 2002) , the presence of S100A4 in the carcinoma cells is associated with a reduced patient survival/poor prognosis, strongly suggesting an association of S100A4 protein and metastasis in human cancer patients. S100A4 belongs to the large S100 family of lowmolecular-weight acidic EF-hand-containing proteins (Kligman and Hilt, 1988; Donato, 1999) . S100 proteins contain two distinct, generally calcium-binding EF hands flanked by hydrophobic regions at either terminus and separated by a central hinge region. The C-EF hand, containing a canonical Ca 2 þ -binding loop, encompasses 12 amino acids and binds calcium with a higher affinity than the N-EF-hand domain, which contains a 14-residue pseudo-or S100-EF-hand binding loop (Donato, 1999) . The region of the S100 proteins between the C-EF hand and the C terminus of the S100 proteins is not well conserved, suggesting that it might be associated with the various roles of the S100 proteins (Donato, 1999) . S100A4 exists in the calcium-free state as a symmetrical homodimer in vitro (Vallely et al., 2002) ; however, the equilibrium between monomers and homodimers observed in the absence of calcium ions is shifted in favour of dimers in the presence of calcium (Tarabykina et al., 2000) . Additionally, S100A4 forms heterodimers with S100A1 in the yeast two-hybrid system (Wang et al., 2000; Tarabykina et al., 2001) . S100A4 has been reported to exhibit Ca 2 þ -dependent interaction with potential target proteins in vitro that include nonmuscle myosin II heavy chain isoform A (NMMHCIIA), actin, nonmuscle tropomyosin, p53, liprin and methionine aminopeptidase (Watanabe et al., 1993; Kriajevska et al., 1994 Kriajevska et al., , 2002 Takenaga et al., 1994; Chen et al., 2001; Ford and Zain, 1995; Grigorian et al., 2001) , suggesting that such interactions may play a role in the metastasis-inducing properties of S100A4. However, it is unclear as to which regions of the S100A4 molecule are critical for the induction of metastasis. Point mutations have now been introduced into the calcium-binding loops of the two EF-hands or the C-terminal 15 amino acids have been deleted, and the consequences of these mutations on S100A4-induced metastasis and cell motility are reported.
Results
Purification of mutant S100A4 proteins cDNAs encoding proteins with an N-EF-hand mutant (E23A, D25A), a C-EF-hand mutant (N65I, D67A) or a deleted C-terminal tail (D87amber) (see Materials and methods) and their protein products are designated mS100A4-N, mS100A4-C and mS100A4-T, respectively. Mutant S100A4 proteins were expressed in bacterial cells and purified as described in Materials and methods. The wild-type and mutant S100A4 proteins were greater than 95% pure as judged by silver staining following polyacrylamide gel electrophoresis (Figure 1 ). The mS100A4-C and mS100A4-N proteins at apparent molecular weight of 9 kDa, and the smaller mS100A4-T at apparent molecular weight of 7 kDa reacted with polyclonal antibodies directed against wild-type S100A4 protein (Figure 1 ). SDS-resistant dimers at apparent molecular weight of 21 kDa were present in the wildtype and C mutant proteins, but such dimers were virtually absent from the T mutant.
Calcium-binding by mutant and wild-type S100A4 proteins
For the mS100A4-N, mutations to calcium-coordinating amino acids E23A and D25A did not affect its ability to bind calcium ions (P ¼ 0.94, Student's t-test, 3 determinations) when challenged with 0.2 mM calcium ions using 45 Ca 2 þ gel overlays (Figure 2 ). In contrast, calcium ion binding by the S100A4 protein bearing mutations in the C-EF-hand, which replaced calcium-coordinating positions N65I and D67A, was reduced to 18% of that of the wild-type protein (P ¼ 0.005). Calcium ion binding by the mS100A4-T, lacking the C-terminal 15 amino acids exhibited only slightly reduced binding of calcium ions to only 74% of that of the wild-type protein, which was not significantly different from that of the wild-type protein (P ¼ 0.188).
Effect of mutations on interaction of S100A4 with NMMHCIIA
The abilities of the mutant S100A4 proteins to bind to rNMMHCIIA were tested using an overlay slot-blot procedure (Materials and methods). Wild-type S100A4 was associated with the band of rNMMHCIIA (Figure 3) . The mS100A4-N protein exhibited slightly reduced, but not statistically significantly different binding compared to the wild-type S100A4 protein (P ¼ 0.06, Student's t-test). In contrast, the mS100A4-T exhibited a highly significantly lower level of binding to rNMMHCIIA than to the wild-type protein (P ¼ 0.0001) under the same conditions, and binding of the mS100A4-C was undetectable, being highly significantly lower than the wild-type protein (Po0.0001, Figure 1 Silver-staining and Western blotting of purified S100A4 s. Purified recombinant wild-type S100A4 (lane W), mS100A4-N (lane N), mS100A4-C (lane C) and mS100A4-T (lane T) were subjected to polyacrylamide gel electrophoresis and the proteins visualized by silver staining (panel a). Western blotting shows the purified recombinant wild-type S100A4 (lane W) and mutant S100A4 s (lanes N, C, T) incubated with a rabbit polyclonal anti-human S100A4 antibody (panel b). The position of the monomer and SDS-resistant dimer bands of S100A4 s are shown. The S100A4-T (lane T) is smaller than that of wild-type S100A4 (lane W) Figure 2 Calcium binding by mutant S100A4 proteins. Recombinant wild-type S100A4 (lane W), mS100A4-N (lane N), mS100A4-C (lane C) and mS100A4-T (lane T) proteins were subjected to polyacrylamide gel electrophoresis, stained with Coomassie blue (panel a), electroblotted onto a PVDF membrane and the membrane was incubated with 45 CaCl 2 , washed and bound radioactivity visualized by autoradiography (panel b). The intensity of each band of radioactivity (panel b) associated with wild-type S100A4 (W), mS100A4-N (N), mS100A4-C (C) and mS100A4-T (T) was quantified as described in Materials and methods and divided by the quantified intensity of the equivalent stained protein band (panel a). The resultant mean intensity ratios7s.d. from three separate experiments are shown (panel c) Mutant S100A4 proteins S Zhang et al Student's t-test). Separate control experiments, in which lysozyme replaced the NMMHCIIA and in which EGTA replaced the calcium ions failed to show any interacting S100A4 bands (not shown).
Using an optical biosensor, the mS100A4-N exhibited a similar extent of binding, and the mS100A4-T exhibited a much lower extent of binding, than wildtype S100A4 to immobilized rNMMHCIIA. The mS100A4-C exhibited virtually undetectable binding to rNMMHCIIA ( Figure 4 and Table 1 ). mS100A4-C and mS100A4-T exhibited lower affinities (Kd 78 and 6.6 mM, respectively), and mS100A4-N exhibited a greater affinity (Kd 26 nM) for rNMMHCIIA than wild-type S100A4 (Kd 600 nM). mS100A4-C and mS100A4-T mutant proteins possessed slower/lower binding sites and mS100A4-N exhibited a somewhat faster/higher binding site for NMMHCIIA.
Capability of the mutated S100A4s to induce metastasis in vivo Rama 37 cells were transfected with pBK-CMV vector alone or with vectors containing the wild-type rat S100A4 gene or one of the three mutated S100A4 genes, mS100A4-N, mS100A4-C or mS100A4-T. The resulting Geneticin-resistant, ring-cloned cell lines were designated Rama-V, Rama-W, Rama-N, Rama-C and Rama-T, respectively and the equivalent pools of transfectants were designated Rama-Vp, Rama-Wp, Rama-Np, Rama-Cp and Rama-Tp. Using Western blotting with an S100A4-specific antibody, S100A4 proteins were observed to be expressed at a similar level in all transfected cell lines, except for Rama-V and all pools except Rama-Vp ( Figure 5 ). For Rama-T and Rama-Tp cells, the only detectable immunoreactive band corresponded to the expected smaller size of the mS100A4-T protein with no band detected corresponding to the size of the wild type S100A4 ( Figure 5 ). RT-PCR of S100A4 mRNAs from the Rama-N, Rama Np, Rama-C, Rama-Cp, Rama-T and Rama-Tp cells and subsequent nucleotide sequencing confirmed the pre- Figure 3 Binding of S100A4 to rNMMHCIIA in vitro by slot-blot overlay. Purified recombinant NMMHCIIA protein was spotted onto PVDF membranes (Materials and methods) and the membranes were incubated with purified recombinant wild type S100A4 (W), mS100A4-T (T), mS100A4-N (N) and mS100A4-C (C) proteins. The membranes were incubated with the antibody directed against wild-type S100A4 and secondary antibody. Bound antibody was detected by chemiluminescence following exposure to autoradiographic film (panel a). The intensities of the bands are shown as the means7standard deviations following quantitative scanning of bands in three separate experiments (panel b) Figure 4 Binding of wild-type and mutant S100A4 s to immobilized NMMHCIIA using an optical biosensor. Purified NMMHCIIA was immobilized on a planar aminosilane surface. After the addition of wild-type S100A4 (W), mS100A4-N (N), mS100A4-C (C) or mutant S100A4-T (T) to 4 mM in the biosensor cuvette, the extent of binding (response in arc s) of the S100A4s was followed in real time for 5 min. Data were collected every 0.3 s during the course of the experiment and analysed using the FastFit software (Materials and methods) (Chen et al., 2001) . b The correlation coefficient of the linear regression through k on values used for obtaining k ass .
c k diss of the mean7s.e. of at least five values at different concentrations of S100A4. No evidence was found for a two-site model of dissociation, suggesting that the S100A4-binding sites on NMMHCIIA were homogeneous. sence of mutant, but the absence of wild-type S100A4 sequences (not shown).
Single subcutaneous injection of cell lines Rama-C, Rama-N, Rama-T, Rama-V or Rama-W or pools, Rama-Cp, Rama-Np, Rama-Tp, Rama-Vp or RamaWp into the mammary fat pads of female syngeneic rats yielded similar incidences of primary mammary tumours (clones, 67-95%; pools, 67-90%). The tumour incidences for cells containing the mutants were not significantly different from those containing the wildtype S100A4 (clones all P>0.05, pools all >0.3, Fisher's exact test, Table 2 ). Amplification by RT-PCR of S100A4 mRNA from the tumours and subsequent nucleotide sequencing confirmed that the anticipated transcripts were expressed in tumours from animals injected with Rama-C, Rama Cp, Rama-N, Rama Np, Rama-T, Rama-Tp, Rama-W and Rama-Wp cells (not shown).
Animals injected with untransfected Rama 37 or Rama-V or Rama 37-Vp cells produced no metastases, but cloned and pooled cells (Rama-W and Rama-Wp) expressing wild-type S100A4 produced metastases in the lungs in 62 and 73%, respectively, of the rats with tumours (Table 2 ). Cloned ( Figure 6a ) and pooled cells (Rama-N and Rama-Np) expressing the mS100A4-N protein yielded incidences of metastases of 63 and 84% respectively ( Table 2 ), values that were not significantly different from the Rama-W or Rama-Wp cells (P ¼ 0.977 and 0.436). In contrast, cloned (Rama-C) or pooled cells (Rama-Cp) transfected with mS100A4-C mutant yielded only 15 and 17% tumour-bearing animals with metastases and cloned (Rama-T) ( Figure 6b ) or pooled cells (Rama-Tp) transfected with mS100A4-T mutant yielded only 4 and 22% of animals with metastases in the lungs, respectively, all values being significantly lower (Po0.0005) than those obtained with Rama-W or Rama-Wp cells (Table 2 ). ) were separated by SDS-PAGE and electroblotted onto PVDF membranes. S100A4 proteins were detected using the rabbit polyclonal anti-human S100A4 antibody and a secondary antibody and visualized by chemiluminescence following exposure to autoradiography film Some of the primary tumours exhibited invasion of peripheral blocks of striated muscle (Table 2 and Figure 6c ). The mammary tumours from rats injected with single-cell cloned (Rama-W) or pooled transfectants (Rama-Wp) exhibited a 58 and 80% incidence of muscle invasion, respectively, and the Rama-N or Rama-Np cells 63 and 90% incidence, respectively, values which were not statistically significantly different from the respective Rama-W or Rama-Wp cells (P ¼ 0.758 and 0.531, Fisher's exact test). In contrast, the Rama-C and Rama-Cp cells yielded only an 18 and 32% incidence of muscle invasion, respectively, values that were significantly different from the Rama-W and Rama-Wp cells (P ¼ 0.001 and 0.011, Fisher's exact test). Similarly, the Rama-T and Rama-Tp cells yielded incidences of muscle invasion of 4 and 29%, respectively, values that were significantly different from the Rama-W and Rama-Wp cells (Po0.0001 and 0.007, Fisher's exact test). There was no evidence of muscle invasion by any of the primary tumours in the animals injected with untransfected Rama 37 or with cloned (Rama-V) or pooled (Rama-Vp) cells. The incidences of histological invasion into peripheral muscle of the primary tumours arising from the cell lines and cell pools bearing the various constructs were linearly correlated (R 2 ¼ 0.97, Po0.0001) with the incidences of metastasis to the lungs (Figure 7) .
Capability of the mutant S100A4s to induce motile and invasive behaviour in culture
The same cell lines and pools that were used in the metastasis assays were tested for chemotactic motility in an FCS gradient using a transwell assay system. For the cloned cell lines and the cell pools, cells expressing wildtype S100A4 had 2.5-3.7 or 2.7-6.2-fold increased motility compared to the parental Rama 37 cells or Rama 37 cells transfected with empty expression vector, respectively (Figure 8 ). The cloned and pooled cells Association between invasion and metastasis in mutant S100A4-transfected cells. Transfectant pools and cell lines, Rama-W, Rama-Wp, Rama-C, Rama-Cp, Rama-N, Rama-Np, Rama-T, Rama-Tp, Rama-V, Rama-Vp and untransfected Rama 37 cells were injected subcutaneously into the mammary fat pads of syngeneic rats. The proportion of animals bearing primary tumours exhibiting muscle invasion is plotted against the proportion of rats exhibiting metastases in the lungs (Materials and methods). Using linear regression analysis, the points fit a straight line with coefficient of regression R 2 ¼ 0.97 with a probability that they do not lie on a straight line of Po0.0001. Clones, m pools expressing mutant N exhibited rates of motility that were not significantly different from the clone or pooled cells expressing wild-type S100A4 (P ¼ 0.83 and 0.68, respectively, Student's t-test). In contrast, cloned cells and pools expressing mutant C or mutant T exhibited rates of motility that were significantly less than wildtype cloned and pooled cells (P ¼ 0.0027, C clone; P ¼ 0.021, C pool; P ¼ 0.001, T clone; P ¼ 0.0132, T pool, Student's t-test) and not significantly different from the parental Rama 37 (P ¼ 0.35, C clone; P ¼ 0.93, C pool; P ¼ 0.06, T clone; P ¼ 0.92, T pool, Student's ttest) or Rama 37 transfected with empty vector (P ¼ 0.63, C clone; P ¼ 0.54, C pool; P ¼ 0.15, T clone; P ¼ 0.39, T pool, Student's t-test). Similar results were obtained in Matrigel invasion assays (Figure 8 ). The cloned cell line and the pooled cells expressing mutant N exhibited rates of invasion that were not significantly different from the clone or pooled cells expressing wildtype S100A4 (P ¼ 0.93 and 0.42 respectively, Student's ttest). Cloned cells and pools expressing mutant C or mutant T exhibited rates of invasion that were highly significantly less than wild-type cloned and pooled cells (Pp0.0001, C clone; P ¼ 0.0062, C pool; Pp0.0001, T clone; P ¼ 0.0066, T pool, Student's t-test) and not significantly different from the parental Rama 37 (P ¼ 1.0, C clone; P ¼ 0.39, C pool; P ¼ 0.58, T clone; P ¼ 0.81, T pool, Student's t-test) or not significantly different from Rama 37 transfected with empty vector (P ¼ 0.13, C clone; P ¼ 0.82 C pool; P ¼ 0.46, T clone; P ¼ 0.65, T pool, Student's t-test). These results show that the rates of both motility and invasion for the mutant S100A4 proteins exhibited the same pattern as the incidences of metastases in vivo.
Discussion
The N-and C-EF hands of S100A4 were mutated and the C-terminal 15 amino acids were deleted by sitedirected mutagenesis. The mutation to the low-affinity N-EF hand did not have any effect upon the binding of calcium at the concentration of about 0.2 mM used in the calcium-binding experiments, as expected for this lowaffinity calcium-binding site. In contrast, mutations N65I and D67A in the higher-affinity C-EF-hand calcium-binding loop reduced calcium binding by 3.8-fold for the purified mutant S100A4 protein, compared to wild-type protein. Similar results on calcium binding have been reported recently using different mutations in the EF hands of S100A4 (Kim and Helfman, 2003) . Whereas the cDNA encoding the protein bearing the N-EF-hand mutation exhibited a metastasis-inducing potential almost identical to that of the cDNA encoding the wild-type protein, the C-EF-hand mutation was statistically significantly fourfold less effective than wildtype S100A4 at inducing a metastatic phenotype when expressed in benign rat mammary tumour cells. This result suggests strongly that the ability of the C-EF hand of S100A4 to bind calcium ions contributes to its ability to induce a metastatic phenotype. However, although the mutational changes were considered minimal, it cannot be ruled out that the two amino-acid changes had secondary consequences on the three-dimensional shape of the protein.
Deletion of the last 15 amino acids of the S100A4 protein beyond helix 4 (Vallely et al., 2002) in the Tmutant was either equally effective (Rama-Tp results) or more effective (Rama-T) at reducing the metastasisinducing potential of the S100A4 protein than the inactivation of the C-EF-hand (Table 2) . However, the mS100A4-T protein exhibited only an average 26% reduction in calcium binding, relative to the wild-type S100A4, suggesting that the ability to bind calcium is not the only factor associated with the metastasisinducing potential of S100A4 and that the overall structure of the C-terminal region of the S100A4 protein may also be important for its metastasis-inducing ability. Since loss of the C-terminal region in the tail mutant reduces target binding almost as completely as the C mutant, these results suggest that target binding is important for the induction of metastasis by S100A4. Binding of S100A4 to a fragment of NMMHCIIA has recently been shown to occur in living human cells (Zhang et al., 2005) . Previous experiments (Kriajevska et al., 1994; Takenaga et al., 1994; Ford and Zain, 1995; Ford et al., 1997; Chen et al., 2001; Grigorian et al., 2001 ) have shown that, at least in vitro, S100A4 interacts with a range of targets including NMMHCIIA, p53, tropomyosin, and actin including two, NMMHCIIA and p53, using biosensor techniques (Chen et al., 2001) . In the present experiments, the interaction of the mutant proteins with NMMHCIIA using two separate methodologies gave broadly similar results. The mS100A4-N exhibited slightly reduced level of binding to NMMHCIIA compared to wild-type protein, which was not statistically significantly different (P ¼ 0.06, Student's t-test). This might have arisen from the changed amino-acid side chains in the N-EF-hand altering the structure of the protein more widely and affecting target binding. In contrast, mS100A4-T and mS100A4-C exhibited markedly reduced or no binding to NMMHCIIA, respectively, compared to wild-type S100A4 protein (both Pp0.0001, Student's t-test). Using the biosensor, the calculated Kd values of 220-600 nM for the interaction between wild-type S100A4 and NMMHCIIA are in agreement with those obtained previously of 646 nM (Wang, Fernig and Barraclough, in preparation) and 760 nM (Chen et al., 2003) . The affinity of binding with NMMHCIIA of the wild-type and mutant S100A4s determined using gel overlays was in the order: mS100A4-C o mS100A4-T o wild-type S100A4 (S100A4-W) o mS100A4-N. Thus the reduced interaction of the T and C mutants with NMMHCIIA could be a consequence of increases in the Kd's relative to the wild-type S100A4 of 11-14-and 130-159-fold, respectively. These increased Kd's were broadly accounted for by 16-fold (T) and 129-fold (C) reductions in k ass , respectively, relative to wild-type S100A4 in the presence of calcium, and little changes in the k diss .
The mS100A4-N protein behaved very differently from the mS100A4-C and mS100A4-T mutants. The mS100A4-N cDNA had a slight, but not statistically significant lowering effect on tumour incidence; however, it was as effective as wild-type protein at inducing a metastatic phenotype in the benign tumour cells. Furthermore, the N mutant protein broadly resembled the wild-type protein in its interaction with NMMHCIIA in gel overlay and biosensor experiments. Since the N-EF hand of S100 proteins generally is believed to bind calcium ions with a low (500 mM) affinity (Scha¨fer, 1996) and the concentration of calcium ions used in the 45 Ca 2 þ overlay experiments was about 0.2 mM, it is unlikely that the binding of calcium to the N-EF hand would have been detected (Scha¨fer, 1996) . Thus, it is not possible to be certain that the N-EF-hand mutation has inactivated calcium binding by the N-EFhand loop. However, in kinetic target binding experiments using the biosensor, there were marked differences in the binding parameters of the mS100A4-N protein compared to the wild-type S100A4. The mutant protein exhibited a Kd that was 3-23-fold lower than that of the wild-type protein, arising from a ninefold higher k ass and a 2.4-fold lower k diss . Thus, the effect of the N mutant on the kinetic parameters of the S100A4/ NMMHCIIA interaction was opposite to that of the mS100A4-C and mS100A4-T mutations, suggesting that the intact N-EF hand might have a moderating effect upon the interaction between S100A4 and NMMHCIIA. Since the N-EF hand binds calcium with a lower affinity, but might be expected to bind calcium at the 0.5 mM concentrations used in the gel overlay and biosensor experiments, this effect might represent a mechanism for limiting the interaction of wild-type S100A4 with at least one of its potential targets, NMMHCIIA, at elevated calcium ion concentrations.
Histological sections from the primary tumours from the rats injected with wild-type and mutant S100A4-transfected cells were examined for evidence of invasion into surrounding muscle. For tumours derived from wild-type S100A4, and the three mutant S100A4s, for both cloned cell lines and pools, the incidence of invasion mimicked closely the incidences of metastasis. It was also found that the invasive behaviour of the cells expressing wild-type and mutant S100A4s in transwell invasion assays in vitro correlated with the metastatic capabilities of the cells. Furthermore, in transwell chemotactic motility assays, the same relationship was found, suggesting strongly a link between motility, invasion and metastasis. In separate experiments, cell lines derived from a transgenic mouse model of S100A4-induced metastasis (Davies et al., 1996) , the relationship between wild-type S100A4 levels and invasive ability was shown to be a consequence of the motile behaviour of the cells (Jenkinson et al., 2004) . Thus, it is possible that the loss of invasive behaviour in the tumours derived from the mS100A4-C and mS100A4-T observed in vivo arises from changes in the ability to induce motility, which might depend, at least in part, upon the interaction of the S100A4s with NMMHCIIA.
While this manuscript was being prepared, Kim and Helfman (2003) reported that mutations to the C-EF hand of S100A4, which inactivated calcium binding, also abrogated interaction with myosin heavy chain IIA. However, the mutant as well as wild-type proteins were localised to the lamellipodia in the breast carcinomaderived cell line MDA-MB-231. The results in the present paper link the ability to bind calcium to the clinical end point of S100A4 action, the process of metastasis, suggesting that calcium-dependent target binding is necessary for this process. However, that the mS100A4-T mutant shows less abrogation of calcium binding but more abrogation of metastasis, than the mS100A4-C mutant, suggests that the Cterminal 15 amino acids of S100A4 are additionally important in processes leading to metastasis.
Materials and methods
Escherichia coli strains, plasmids and general molecular biology procedures E. coli strain DH5a cells were made competent for DNA uptake with calcium chloride (Sambrook et al., 1989 (Gibbs et al., 1994) , and cells were made competent for each experiment using electroporation (Dower et al., 1988) . Production of plasmid pJLA602.S100A4 containing the rat S100A4 cDNA was described previously (Gibbs et al., 1994) . Digestion of plasmid DNA with restriction enzymes, agarose gel electrophoresis of DNA, purification of DNA from low melting point agarose gels, ligation of DNA, transformation of competent E. coli cells were carried out using standard procedures (Sambrook et al., 1989) . DNA sequencing was carried out by the University of Liverpool School of Tropical Medicine.
Mutagenesis of the rat S100A4 cDNA Point mutations were introduced into the S100A4 cDNA to convert calcium-coordinating amino acids in the loop of the N-EF-hand E23, D25 to A; calcium-coordinating amino acids in the loop of the C-EF-hand N65 to I, and D67 to A; the codon for N87 was altered to an amber termination codon, thereby deleting the last 15 amino acids of the S100A4 protein. All mutations were introduced using site-directed mutagenesis by PCR (Ho et al., 1989) using the plasmid pJLA-S100A4 (Gibbs et al., 1994) , designated pJLA.S100A4-W, as a template with the following primers (mutations underlined, enumerated according to the rat S100A4 cDNA sequence, GenBank Accession Number 012618) to incorporate the mutations: for E23A and D25A, forward: 5 0 -(116)CAACGCGGGTGCCAA GTTCAAGCTGAA (142) 0 . Full-length S100A4 was produced using the following primers within the pJLA vector (Schauder et al., 1987) containing flanking XhoI and BamHI sites (underlined): forward 5 0 -TTGGCGCCTCGAGTAAT-3 0 , reverse 5 0 -CATA-GACGGATCCCTGCAGTT-3 0 . The N87Amber mutation (underlined) was generated using the forward pJLA primer above and reverse primer : 5 0 -(324)CAAAGAATTCCTAG-CACATCATGGCA(299)-3 0 . Amber mutant S100A4 cDNA was produced using forward and reverse pJLA primers above. The 0.51 kbp (for full-length W, N and C) and 0.33 kbp (for trunctated T) cDNAs were purified from agarose gels (QIAquick). The nucleotide sequences of these mutant cDNAs was checked by DNA sequencing prior to being subcloned back into expression plasmid pJLA 602 using the restriction enzyme sites flanking the cDNAs to yield plasmids designated pJLA.S100A4-N, pJLA.S100A4-C, pJLA.S100A4-T.
For transfection into Rama 37 cells, the wild-type and mutant cDNAs were transferred into Plasmid pBK-CMV (Stratagene) from the pJLA plasmid by amplifying the inserts by PCR using the following primers: forward primer (HindIII site underlined) 5 0 -CCCAAGCTTGCCGCCATGGCGAGAC CCTTGGAG-3 0 (for W, N, C and T), reverse primer (XbaI site underlined) 5 0 -GACTCTAGACTGCAGTTTCAAAAC-3 0 (derived from pJLA sequences for W, N and C), reverse primer (EcoRI site underlined) 5 0 -CAAAGAATTCCTAGCA-CATCATGGCA-3 0 (for mutant T). PCR products were purified from an agarose gel and the S100A4 cDNAs were digested with HindIII and XbaI, and subsequently ligated into HindIII-and XbaI-cut plasmid vector pBK-CMV to form pBK.S100A4-W, pBK.S100A4-N, pBK.S100A4-C, pBK. S100A4-T. The plasmids were propagated in E. coli strain XL1blue (Stratagene) using standard procedures (Sambrook et al., 1989) .
Purified plasmids, pJLA.S100A4-W, pJLA.S100A4-N, pJLA.S100A4-C, pJLA.S100A4-T were used to produce recombinant S100A4s which were purified and analysed by SDS-PAGE (Gibbs et al., 1994) . Concentrations of rS100A4 were determined using Coomassie blue (Bio-Rad Laboratories) according to the manufacturer's instructions. Purified recombinant S100A4 s were stored in aliquots at À701C. The purity of S100A4 preparations was determined by silver staining of overloaded polyacrylamide gels. The proteins containing the N-EF-hand and the C-EF-hand mutations and the deleted C-terminal tail are designated mS100A4-N, mS100A4-C and mS100A4-T, respectively. The location of the C-EF-hand, N-EF-hand and C-terminal tail mutations in the structure of the S100A4 protein are shown in Figure 9 . Production and purification of a recombinant fragment of NMMHCIIA was described previously (Chen et al., 2001) .
Western blotting
Western blot analysis was performed as described previously (Gibbs et al., 1994) using a rabbit polyclonal anti-human S100A4 antibody (Dako, England) as primary antibody. Membranes were incubated in enhanced chemiluminescence reagent (Pierce, USA) and exposed to autoradiographic film (Eastman Kodak, Rochester, NY).
Detection of calcium binding by mutant proteins using 45 
CaCl 2 overlay
Proteins were separated by SDS-PAGE and electrophoretically transferred to Immobilon PVDF-based membranes (Millipore Corporation, France). The membranes were washed three times for 20 min in 5 mM MgCl 2 , 10 mM imidazole-HCl (pH 6.8). The membranes were incubated for 20 min with this buffer containing 1 mCi/L 45 CaCl 2 (Dupont NEN; concentra- Figure 9 Mutations of the S100A4 protein. The NMR-derived three-dimensional structure of the calcium-free dimeric S100A4 molecule (Vallely et al., 2002) is shown from the GenBank database, structure 1M31, displayed using the CN3D programme (NCBI). The positions on the structure of the N-EF-hand mutation (N), the C-EF-hand mutation (C) and the C-terminal 15-aminoacid deletion (T) are shown by the white circles Mutant S100A4 proteins S Zhang et al tion of CaCl 2 not less than 0.20 mM) and washed with distilled water. After being dried, the membranes were exposed to Kodak X-Omat X-ray film for 24-48 h at room temperature (Barraclough et al., 1990) . The autoradiographic images were scanned using a CCD camera and semiquantitative analysis carried out using Image 1.44 (NIH, Bethesda, USA). The mean pixel intensities of the images of the bands represented band intensities. Experiments for semiquantitative analysis were repeated three times.
Interaction of S100A4 with NMMHCIIA by overlay slot blotting
An amount of 15 mg of rNMMHCIIA, diluted in Tris-buffered saline (TBS) (50 mM Tris, 100 mM NaCl, pH 7.2), was adsorbed in each well of a slot-blot apparatus onto an Immobilon PVDF membrane (Millipore). The membrane was stained with fast green to ensure equal retention of NMMHCIIA. The membrane was blocked in TBS solution (50 mM Tris, 100 mM NaCl, pH7.2) containing 1% (w/v) bovine serum albumin (BSA) at room temperature for 1 h, and washed four times for 5 min each in Washing Buffer (50 mM Tris, 100 mM NaCl, 2 mM DTT, 0.3 % (w/v) Nonidet P-40, 2% (w/v) Marvel, pH7.2). A volume of 400 ml of Overlay Buffer (50 mM Tris, 100 mM NaCl, 2 mM DTT, 0.5% (w/v) BSA, 0.25% (w/v) gelatin, 0.3% (w/v) Nonidet P-40, pH 7.2) containing 500 mM CaCl 2 or 1 mM EGTA, 5 mM (60 mg/ml, 24 mg) purified wild-type or mutant S100A4 proteins, or an equal amount of lysozyme as a negative control, were applied to the wells, incubated overnight at 41C, and then extracted under gentle vacuum. The membrane was washed four times for 5 min each in Washing Buffer and incubated in a sealed bag with 2.5 ml of a 500-fold dilution of the rabbit anti-human S100A4 polyclonal antibody (Dako) at room temperature for 2 h. After being washed three times for 5 min each in Washing Buffer, the membrane was incubated in a 3000-fold dilution of a peroxidase-conjugated goat anti-rabbit IgG (A-9169, Sigma) for 1 h and with enhanced chemiluminescence reagent (Pierce, USA). S100A4 bound to the membrane was detected by exposure to autoradiographic film (Eastman Kodak, Rochester, NY, USA).
Interaction of wild-type and mutant S100A4s with NMMHCIIA using an optical biosensor
Binding reactions were carried out in an IAsys resonant mirror biosensor (Affinity Sensors, Saxon Hill, Cambridge, UK) at 201C on planar aminosilane surfaces derivatized with human rNMMHCIIA using a BS 3 spacer (Pierce-Warriner, Chester, UK) according to the manufacturer's instructions. A resonance scan showed that the immobilized NMMHCIIA and bound ligands were distributed uniformly on the surface and not microaggregated. None of the ligates at the concentrations used in the experiments bound to nonderivatized aminosilane surfaces (not shown).
Binding assays were carried out as described previously (Rahmoune et al., 1998) , and the extents of binding of S100A4 to the surface are given in arc s (1 arc s ¼ 1/36001). S100A4 proteins were added in 30 ml of PBST (140 mM NaCl, 5 mM NaH 2 PO 4 , 5 mM Na 2 HPO 4 , 0.02% (v/v) Tween 20, pH 7.2) containing 500 mM calcium, and the association reactions were followed for at least 5 min. Cuvettes were washed twice with 50 ml of PBST with 500 mM calcium, and the dissociation of bound ligate into the PBST was followed for at least 2 min. The immobilized ligand was regenerated as described previously (Chen et al., 2001) . Binding parameters were calculated from the association and dissociation rate constants, k ass and k diss , respectively, from two experiments, using the nonlinear curve fitting FastFit software (Affinity Sensors).
Cell culture and stable transfection of S100A4 constructs into Rama 37 cells
The derivation and culture of the cell line, Rama 37, has been described before (Dunnington et al., 1983) . Stable transfection of 10 5 Rama 37 cells with empty pBK-CMV vector, or pBK-CMV vector containing mutant or wild-type cDNAs, was carried out using lipofectamine reagent as described by the supplier (Invitrogen, Paisley, Scotland). Colonies of cells surviving after 2 weeks of selection in 1 mg/ml Geneticin were ring cloned and the remaining uncloned cells were allowed to grow to form a pool of transfected cells. The expression of the S100A4 mRNA and protein in the clones and pools were determined by reverse transcript PCR (RT-PCR) and Western blotting, respectively.
Testing cell lines and tumours for expression of mutant S100A4 proteins
Total RNA was isolated from washed, snap-frozen, cloned transfected cells from one 3.5 cm Petri dish using TRIZOL (Invitrogen), as described by the supplier. The resulting RNA pellet was briefly air-dried and dissolved in 20 ml of RNase-free water and stored at À701C. The quality of the RNA was monitored by electrophoresis on 1.5% (w/v) agarose gels containing formaldehyde (Sambrook et al., 1989) . Bands of RNA were visualised using a UV transilluminator (302 nm).
The presence of mRNA for mutant or wild-type S100A4 mRNA in the cells was tested using RT-PCR. cDNA was synthesised from cell line RNA using a cloned-AMV FirstStrand Synthesis Kit (Invitrogen) and S100A4 mutant and wild-type DNA amplified using a specific rat S100A4 cDNA forward primer, 5 0 -(73)AGGCCCTGGATGTAATAGTG(92) -3 0 , and a specific pBK-CMV (Stratagene) vector 3 0 primer: 5 0 -CTGTTGGGAAGGGCGATC-3 0 . The temperature profile used was: one cycle at 941C for 2 min; 35 cycles of 941C for 45 s, 561C for 40 s and 721C for 1 min; followed by one cycle at 721C for 7 min. Cell lines exhibiting expression of S100A4-W, mS100A4-N, mS100A4-C and mS100A4-T are designated Rama-W, Rama-N, Rama-C and Rama-T, respectively. A cell line transfected with empty pBK-CMV vector exhibiting undetectable levels of wild-type S100A4 mRNA is designated Rama-V.
RNA was isolated from tumour tissues using the guanidinium isothiocyanate/CsCl method as described previously (Chirgwin et al., 1979; Anandappa et al., 1994) . For RT-PCR, 3 mg of total RNA was reverse transcribed and subjected to 40 cycles of PCR as described above. Samples of the PCR reactions were subjected to agarose gel electrophoresis, purified and sequenced. Control amplifications in which the reverse transcriptase was omitted were negative, showing that the bands were not arising from amplification of DNA in the RNA preparations.
For detection of the wild-type and mutant S100A4 proteins in transfected Rama 37 cells, near-confluent cultures in 9 cm dishes were harvested into 4% (w/v) SDS, 12% (w/v) glycerol, 50 mM Tris-HCl, 2% (v/v) mercaptoethanol, pH 6.8. Equal amounts of total proteins were separated by polyacrylamide gel electrophoresis (Schagger and Von Jagow, 1987) and electroblotted onto Immobilon PVDF membranes (Millipore). S100A4 protein was detected as described for the Western blot experiments.
Tumorigenicity and metastasis
A total of 2 Â 10 6 cultured Rama 37 or clones or pools of transfectant cells were harvested, prepared and injected subcutaneously into the right or left inguinal mammary fat pads of 4-6-week old female Wistar-Furth rats (LudwigWistar OLA strain, Olac, Banbury, Oxon, UK), as described previously (Davies et al., 1993) . Rats were observed twice weekly and autopsied when the primary tumour reached 5 cm in diameter, or after 3 months. Samples of the primary tumour, lungs and any other tissues of abnormal appearance were fixed in Methacarn (methanol-Inhibisol-acetic acid 6 : 3 : 1), embedded in paraffin wax, sectioned for histology and stained with haematoxylin and eosin (Dunnington et al., 1983) . Five microscopic fields from at least two sections of each tumour/tissue were examined by two independent observers (Davies et al., 1993) . Animals containing microscopically visible metastases of malignant cells in the lungs and blocks of striated muscle infiltrated by malignant cells at the periphery of the primary tumours were scored positive for metastasis and invasion, respectively. Animals from which no lungs were recovered, or which contained no visible muscle blocks bordering the primary tumours, were eliminated from further analysis. Photographs were recorded in a ReichertPolyvar microscope using a Wratten No. 44 filter. Animals were maintained according to UKCCCR guidelines under UK Home office Project Licence No. 40/2395 to Professor P.S. Rudland.
Motility and invasion assays
The motile and invasive abilities of the cloned cell lines and pools through a filter were measured using a 24-well plate Boyden chamber transwell assay system (Corning Costar, High Wycombe, Bucks, UK) containing 8 mm pores. Chemotactic-induced motility, in response to a FCS concentration gradient, was measured by adding 600 ml of Routine Medium containing 10% (v/v) FCS to the lower compartment, and 7 Â 10 3 cells in 100 ml of Routine Medium containing 2% (v/v) FCS to the upper chamber. The cells were incubated at 371C, 10% (v/v) CO 2 for 18 h, and nonmotile cells on the upper side of the filter were removed with a cotton swab. Motile cells on the under-side of the filter were fixed, stained using Diffquik histochemical stain (Dade Behring, Du¨dingen, Switzerland) according to the manufacturer's instructions and counted using a Dynascope microscope (Vision Engineering, Woking, Surrey, UK). The lower compartment was checked for the absence of cells and for each cell line or pool, the results are the mean of three independent experiments.
For cell invasion, the filters were each coated with 30 mg Matrigel (Collaborative Biomedical Products, Becton Dickinson, Oxford, UK) and the assays carried out as described above for chemotactic motility, except that 20 Â 10 3 cloned or pooled cells in 100 ml of Routine Medium with 2% (v/v) FCS were added to the upper compartment and the cells were incubated for 24 h.
